Angel News
Angel News
Angel News

Back to Homepage

16th January 2019

The venture capital market – a year in review and trends to anticipate

Alex Sleigh, Investment Director at Newable shares his thoughts on trends from last year, what to expect for 2019 and how the upcoming year will impact businesses at the heart of the economy.

16th January 2019

School Space secures £800,000 to help schools generate revenue

 

School Space, a leading platform for schools to generate extra funds by hiring out their spaces, has announced that it has secured £800,000 in equity funding with the help of ClearlySo, Europe’s leading impact investment bank.

 

16th January 2019

Maven managed funds leads £1.95m investment in Dyer Engineering

 

Maven Capital Partners, one of the UK’s most active private equity houses, has, through its management of two regional funds, provided £1.95 million of capital to Dyer Engineering Ltd, the largest independent engineering business in County Durham. The North East Development Fund, supported by the European Regional Development Fund and the Finance Durham Fund, established by and using funds from Durham County Council have respectively invested £1 million and £750,000, with an additional £200,000 sourced from a local private investor. The investment will support the company’s growth plans to exploit new opportunities in multiple industries and will create up to 100 new jobs in the region.

 

16th January 2019

BGF exits Jumpstart

 

BGF has announced the exit of its minority investment in Jumpstart, the UK's leading R&D tax credit specialists, as the business is acquired by Visiativ Group. Visiativ’s Consulting division, ABGI, will acquire Jumpstart following a period of acquisitive expansion and growth.

 

16th January 2019

Sanford DeLand appoints Rex Orton as new Chairman of the Board

 

The Board of Sanford DeLand Asset Management (SDL) has announced the appointment of Rex Orton as Chairman with immediate effect, following FCA approval.

 

15th January 2019

Business formations recover to reach new high in 2018 says CFE research

he latest Companies House data, as analysed by the Centre for Entrepreneurs (CFE), shows that business formations recovered from a drop in 2017 to reach a record 663,272 in 2018.

 

“It is encouraging to see formation numbers recover and hit a new high,” says Matt Smith, director of the Centre for Entrepreneurs. “These figures demonstrate the resilience and confidence of entrepreneurs across the country, confirmed by a 5.7% increase of business registrations and the strengthening of London as Europe’s leading startup hub.”

15th January 2019

European venture capital’s “new normal”

eFront, the leading financial software and solutions provider dedicated to Alternative Investments, has published its latest Quarterly Private Equity Performance report, showing that venture capital funds globally currently offer a highly attractive risk-return profile, with Western European funds significantly outperforming the historical average.

Key findings

  • Performance, risk and holding periods of global venture capital funds have both fallen over the last two quarters, hinting at a wave of new investments.
  • Risk-adjusted performance, however, has improved markedly, with risk levels returning to pre-2013 levels and returns remaining above 1.4x.
  • Western European venture capital funds are setting a “new normal” for returns, with performance consistently higher than the historical average and convergence with US performance on the horizon. Performance is led by the extremely strong 2009 and 2010 vintage years, while 2011-15 funds are also performing well.
  • The picture of US venture funds is increasingly contrasted, with vintage years 2009 and 2011 underperforming, while 2010, 2012 and 2015 significantly outperform.
  • The average number of years companies are held in portfolios dropped sharply in 2018.

15th January 2019

IGF bolsters ABL sales team after record-breaking year
Independent Growth Finance (IGF), the leading independent asset based lender, today announces further investment in its asset based lending sales team following a record year.

With 17 years’ experience working in asset based lending and invoice finance, the appointment of Nigel Hibbert as ABL director strengthens IGF’s presence in the South East. Following this latest appointment, IGF’s ABL sales team has increased 50 percent in the last 12 months.

15th January 2019

Goldman Sachs leads $8m investment in Immersive Labs

Immersive Labs has announced that Goldman Sachs has led an $8m Series A investment round in its fast-growing cyber security skills platform. The funding, made alongside smaller private investors, will grow an offering which arms enterprise IT and cyber security teams with the latest skills by combining threat data with gamified learning.   The award-winning Immersive Labs platform uses real-time feeds of the latest attack techniques, hacker psychology and technological vulnerabilities to rapidly

15th January 2019

Heartwood launches new dynamic reporting solution

Heartwood Investment Management, the asset management arm of Handelsbanken in the UK, 

14th January 2019

Private clients increasingly interested in private capital exposure

By Robert Crowter-Jones, Head of Private Capital at Saranac Partners

Families now tend to allocate 10-30% of their total assets into private capital investments, with debt/equity exposure via funds and direct investments growing year-on-year

14th January 2019

Chronomics secures £1.12 million seed funding

Chronomics, a pioneering company in health-tech innovation, has just launched the world’s first consumer epigenetic testing kit. Chronomics has successfully secured more than £1.12 million in funding, including significant investment from venture capital firm Anthemis, and follow on funding from SOSV, one of the world’s most active early stage biotech investors.

The four founders of Chronomics are leading in their respective fields. Dr Tom Stubbs and Daniel Herranz worked at the forefront of epigenetics research at the University of Cambridge, where they collaborated with Dr Toby Call, a Bioenergy and Industrial Biotechnology expert, to define the first models. The team brought on board Charles Ball whose extensive commercial experience has helped to explain the intricacies of epigenetic science to the public.

Items of 2221NEXT

Back to Homepage